Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
This study has been completed.
Study NCT00538434   Information provided by Ception Therapeutics
First Received: October 1, 2007   Last Updated: October 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eosinophilic Esophagitis
Additional conditions recognized in this trial
Esophagitis
More general conditions related to this trial
Digestive System Diseases
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Interventions listed in this trial
Reslizumab
Saline
Sponsors listed in this trial
Ception Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services